Heparan sulfate increases survival during gut-derived sepsis by decreasing bacterial translocation and enhancing host defense.

R. Gennari, J. W. Alexander, Tonyia Eaves-Pyles, G. F. Babcock

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effect of heparan sulfate (HS) on survival rate, bacterial translocation, and host defense was studied in a model of gut-derived sepsis that included transfusion-induced immunosuppression. Balb/c mice were treated pre- and postburn injury and bacterial challenge with HS, 5 mg/kg/day, or sterile phosphate-buffered saline. The HS pre- and postburn treated animals showed a significant improvement in survival compared to control animals (80 vs. 30%, p = .004, and 60 vs. 20%, p = .02, respectively). A lower amount of translocation was observed in the spleen (p < or = .001) of the HS group compared to control group. Quantitative colony counts and the calculated percentage of viable bacteria showed that the ability to kill translocated organisms was enhanced in all tissues of the animals receiving HS. These data suggest that treatment with HS positively affects the outcome in gut-derived sepsis. The beneficial effect was related both to an improved gut barrier function and to an enhanced host defense.

Original languageEnglish (US)
Pages (from-to)246-250
Number of pages5
JournalShock (Augusta, Ga.)
Volume2
Issue number4
StatePublished - Oct 1994
Externally publishedYes

Fingerprint

Bacterial Translocation
Heparitin Sulfate
Sepsis
Immunosuppression
Spleen
Phosphates
Bacteria
Control Groups
Wounds and Injuries

ASJC Scopus subject areas

  • Physiology
  • Critical Care and Intensive Care Medicine

Cite this

Heparan sulfate increases survival during gut-derived sepsis by decreasing bacterial translocation and enhancing host defense. / Gennari, R.; Alexander, J. W.; Eaves-Pyles, Tonyia; Babcock, G. F.

In: Shock (Augusta, Ga.), Vol. 2, No. 4, 10.1994, p. 246-250.

Research output: Contribution to journalArticle

@article{da01eb7013084795ad24019c2ca35b6a,
title = "Heparan sulfate increases survival during gut-derived sepsis by decreasing bacterial translocation and enhancing host defense.",
abstract = "The effect of heparan sulfate (HS) on survival rate, bacterial translocation, and host defense was studied in a model of gut-derived sepsis that included transfusion-induced immunosuppression. Balb/c mice were treated pre- and postburn injury and bacterial challenge with HS, 5 mg/kg/day, or sterile phosphate-buffered saline. The HS pre- and postburn treated animals showed a significant improvement in survival compared to control animals (80 vs. 30{\%}, p = .004, and 60 vs. 20{\%}, p = .02, respectively). A lower amount of translocation was observed in the spleen (p < or = .001) of the HS group compared to control group. Quantitative colony counts and the calculated percentage of viable bacteria showed that the ability to kill translocated organisms was enhanced in all tissues of the animals receiving HS. These data suggest that treatment with HS positively affects the outcome in gut-derived sepsis. The beneficial effect was related both to an improved gut barrier function and to an enhanced host defense.",
author = "R. Gennari and Alexander, {J. W.} and Tonyia Eaves-Pyles and Babcock, {G. F.}",
year = "1994",
month = "10",
language = "English (US)",
volume = "2",
pages = "246--250",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Heparan sulfate increases survival during gut-derived sepsis by decreasing bacterial translocation and enhancing host defense.

AU - Gennari, R.

AU - Alexander, J. W.

AU - Eaves-Pyles, Tonyia

AU - Babcock, G. F.

PY - 1994/10

Y1 - 1994/10

N2 - The effect of heparan sulfate (HS) on survival rate, bacterial translocation, and host defense was studied in a model of gut-derived sepsis that included transfusion-induced immunosuppression. Balb/c mice were treated pre- and postburn injury and bacterial challenge with HS, 5 mg/kg/day, or sterile phosphate-buffered saline. The HS pre- and postburn treated animals showed a significant improvement in survival compared to control animals (80 vs. 30%, p = .004, and 60 vs. 20%, p = .02, respectively). A lower amount of translocation was observed in the spleen (p < or = .001) of the HS group compared to control group. Quantitative colony counts and the calculated percentage of viable bacteria showed that the ability to kill translocated organisms was enhanced in all tissues of the animals receiving HS. These data suggest that treatment with HS positively affects the outcome in gut-derived sepsis. The beneficial effect was related both to an improved gut barrier function and to an enhanced host defense.

AB - The effect of heparan sulfate (HS) on survival rate, bacterial translocation, and host defense was studied in a model of gut-derived sepsis that included transfusion-induced immunosuppression. Balb/c mice were treated pre- and postburn injury and bacterial challenge with HS, 5 mg/kg/day, or sterile phosphate-buffered saline. The HS pre- and postburn treated animals showed a significant improvement in survival compared to control animals (80 vs. 30%, p = .004, and 60 vs. 20%, p = .02, respectively). A lower amount of translocation was observed in the spleen (p < or = .001) of the HS group compared to control group. Quantitative colony counts and the calculated percentage of viable bacteria showed that the ability to kill translocated organisms was enhanced in all tissues of the animals receiving HS. These data suggest that treatment with HS positively affects the outcome in gut-derived sepsis. The beneficial effect was related both to an improved gut barrier function and to an enhanced host defense.

UR - http://www.scopus.com/inward/record.url?scp=0028523882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028523882&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 246

EP - 250

JO - Shock

JF - Shock

SN - 1073-2322

IS - 4

ER -